Visceral leishmaniasis in immunocompromised patients with and without AIDS: A comparison of clinical features and prognosis

Acta Tropica

Volumn 90, Issue 1, 2004, Pages 11-16

  Fernández Guerrero, Manuel L ^a   Robles, Pablo ^a   Rivas, Pablo ^a   Mójer, Francisca ^a   Muñíz, Gemma ^a   De Górgolas, Miguel ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

AIDS; Immunocompromised hosts; Kala azar; Visceral leishmaniasis

Indexed keywords

AMPHOTERICIN; AZATHIOPRINE; CORTICOSTEROID; GAMMA INTERFERON; IMMUNOSUPPRESSIVE AGENT; MEGLUMINE ANTIMONATE; MEGLUMINE ANTIMONATE PLUS GAMMA INTERFERON; PREDNISOLONE; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; LEISHMANIASIS;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD DISEASE; BONE MARROW BIOPSY; CHEMICAL ANALYSIS; CLINICAL FEATURE; CONTROLLED STUDY; CYTOPENIA; FEMALE; FEVER; GRAFT REJECTION; HEART VENTRICLE ARRHYTHMIA; HEPATOMEGALY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MALE; PATIENT; PROGNOSIS; RELAPSE; SERODIAGNOSIS; SEROLOGY; SPLENOMEGALY; TREATMENT FAILURE; TREATMENT OUTCOME; VISCERAL LEISHMANIASIS;

NASO HEXACANTHUS;

EID: 1642565137     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2003.09.009     Document Type: Article

References (33)

1. Alvar J., Cañavate C., Gutiérrez S.B., Jiménez M., Laguna F., López Vélez R., Molina R., Moreno J. Leishmania and human immunodeficiency virus co-infection: the first ten years. Clin. Microbiol. Rev. 10:1997;298-319.
2. Badaró R., Jones T.C., Carvalho E.M., Sampaio D., Reed S.G., Barral A., Teixeira R., Johnson W. Jr. New perspectives on a subclinical form of visceral leishmaniasis. J. Infect. Dis. 154:1986a;1003-1011.
3. Badaró R., Carvalho E.M., Rocha H., Queiroz A.C., Jones T.C. Leishmania donovani: an opportunistic microbe associated with progressive disease in three immunocompromised patients. Lancet. 1:1986b;647-648.
4. Benito N., Núñez A., Górgolas M., Esteban J., Calabuig M.T., Rivas M.C., Fernández Guerrero M.L. Bone marrow biopsy in the diagnosis of fever of unknown origin in patients with acquired immunodeficiency syndrome. Arch. Int. Med. 157:1997;1577-1580.
5. Berenguer J., Moreno S., Cercenado E., Bernaldo de Quirós J.C., García de la Fuente A., Bouza E. Visceral leishmaniasis in patients infected with human immunodeficiency virus (HIV). Ann. Int. Med. 111:1989;129-132.
6. Berenguer J., Gómez-Campdera F., Padilla B., Rodriguez Ferrero M., Anaya F., Moreno S., Valderrábano F. Visceral leishmaniasis (Kala-azar) in transplant recipients. Transplantation. 65:1998;1401-1404.
7. Berhe N., Hailu A., Wolday D., Negesse Y., Cenini P., Frommel D. Ethiopian visceral leishmaniasis patients co-infected with human immunodeficiency virus. Trans. R. Soc. Trop. Med. Hyg. 89:1995;205-207.
8. Berman J.D. Human leishmaniasis: clinical diagnostic and chemotherapeutic developments in the last ten years. Clin. Infect. Dis. 24:1997;684-703.
9. Biggar R.J., Goedert J.J., Hoofnagle J. Accelerated loss of antibody to hepatitis B surface antigen among immunodeficient homosexual men infected with HIV. N. Engl. J. Med. 316:1987;630-631.
10. Centers for Disease Control and Prevention, 1992. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morb. Mortal. Wkly. Rep. 41, 1-19.
11. Davidson R.N., Russo R. Relapse of visceral leishmaniasis in patients who were coinfected with human immunodeficiency virus and who received treatment with liposomal amphotericin B. Clin. Infect. Dis. 19:1994;560.
12. Fernández Guerrero M.L., Aguado J.M., Buzón L., Barros C., Montalbán C., Martín T., Bouza E. Visceral leishmaniasis in immunocompromised hosts. Am. J. Med. 83:1987;1098-1102.
13. Górgolas M., Castrillo J.M., Fernández Guerrero M.L. Visceral leishmaniasis in patients with AIDS: report of three cases treated with pentavalent antimoniate and interferon-gamma. Clin. Infect. Dis. 17:1993;56-58.
14. Górgolas M., Bello E., Blanco A., Renedo G., Fernández Guerrero M.L. Invasive infection of the gastrointestinal tract by Leishmania in patients with AIDS. Infect. Dis. Clin. Prac. 6:1997;153-158.
15. Gradoni L., Bryceson A.D., Desjeux P. Treatment of mediterranean visceral leishmaniasis. Bull. World Health Org. 73:1995;191-197.
16. Haas J.S., Bolan G., Larsen S.A., Clement M.J., Bacchetti P., Moss A.R. Sensitivity of treponemal tests for detecting prior treated syphilis during human immunodeficiency virus infection. J. Infect. Dis. 162:1990;862-866.
17. Hussein M.M., Mooij J.M., Roujouleh H.M., Hamour O.A., Felemban H. Non-typhoidal salmonella septicemia and visceral leishmaniasis in a renal transplant recipient. Transplantation. 71:2001;479-481.
18. Kar K. Serodiagnosis of leishmaniasis. Crit. Rev. Microbiol. 21:1995;123-152.
19. Kemp M., Hansen M.B., Theander T.G. Recognition of leishmania antigens by T lymphocytes from nonexposed individuals. Infect. Immun. 60:1992;2246-2251.
20. Laguna F., López Vélez R., Pulido F., Salas A., Torre-Cisneros C.J., Torres E., Medrano F.J., Sanz J., Pico G., Gómez-Rodrigo J., Pasquau J., Alvar J. Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B. AIDS. 13:1999;1063-1069.
21. Lane H., Masur H., Edgar L.C., Whalen G., Rook A.H., Fauci A. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 309:1983;453-458.
22. López Vélez R., Pérez Moa J.A., Guerrero A., Baquero F., Villarubia J., Escribano L., Bellas C., Pérez Corral F., Alvar J. Clinico-epidemiological characteristics, prognostic factors and survival analysis of patients coinfected with HIV and leishmania in an area of Madrid, Spain. Am. J. Trop. Med. Hyg. 58:1999;436-443.
23. Magill A.J., Gasser R.A., Oster C.N., Grogl M., Sun W. Viscerotropic leishmaniasis in persons returning from Operation Desert Storm 1990-1991. JAMA. 267:1992;1444-1446.
24. Montalban C., Martínez F.R., Calleja J.L., García D.J., Rubio R., Dronda F., Moreno S., Yebra M., Barros C., Cobo J. Visceral leishmaniasis (Kala-azar) as an opportunistic infection in patients infected with the human immunodeficiency virus in Spain. Rev. Infect. Dis. 11:1989;655-660.
25. Peters B.S., Fish D., Golden R., Evans D.A., Bryceson A.D., Pinching A.J. Visceral leishmaniasis in HIV infection and AIDS: clinical features and response to therapy. QJM. 77:1990;1101-1111.
26. Pintado V., Martin-Rabadán P., Rivera M.L., Moreno S., Bouza E. Visceral leishmaniasis in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients. Medicine. 80:2001;54-73.
27. Portoles J., Prats D., Torralbo A., Herrero J.A., Torrente J., Barrientos A. Visceral leishmaniasis: a cause of opportunistic infection in renal transplant patients in endemic areas. Transplantation. 57:1994;1677-1679.
28. Raffi F., Merrien D., Le Pape P., Reliquet V. Use of itraconazole/ allopurinol combination for the treatment of visceral leishmaniasis in a patient with AIDS. Clin. Infect. Dis. 21:1995;1338-1339.
29. Rosenthal E., Marty P., del Giudice P., Pradier C., Ceppi C., Gastaut J.A., Le Fichoux Y., Cassuto J.P. HIV and Leishmania co-infection: a review of 91 cases with focus on atypical locations of leishmania. Clin. Infect. Dis. 31:2000;1093-1095.
30. Sacks D.J., Suman Lata L., Shrivastava S.N., Blackwell J., Neva F.A. An analysis of T cell responsiveness in Indian Kala-azar. J. Immunol. 138:1987;908-913.
31. Sundar S., Jha T.K., Thakur C.P., Engel J., Sindermann H., Fischer C., Junge K., Bryceson A., Berman J. Oral miltefosine for Indian visceraql leishmaniasis. N. Engl. J. Med. 347:2002;1739-1746.
32. Uyemura K., Pirmez C., Sieling P.A., Kiene K., Paes-Oliveira M., Modlin R.L. CD4+ Type 1 and CD8+ Type 2 T cell subsets in human leishmaniasis have distinct T cell receptor repertoires. J. Immunol. 151:1993;7095-7104.
33. World Health Organization, 1997. Leishmania/HIV co-infection. Epidemiological analysis of 692 retrospective cases. Wkly. Epidemiol. Rec.72, 49-54.